The NET G3 enigma: dealing with a “new” entity
The objective of this short review is to summarize pathological characteristics as well as therapeutic data obtained in patients with NET G3.
Source: Memo - Magazine of European Medical Oncology - Category: Cancer & Oncology Source Type: research
More News: Brain | Cancer & Oncology | Carcinoma | Chemotherapy | Gastroenterology | International Medicine & Public Health | Neurology | Undifferentiated Carcinoma | WHO